文献速递系统性红斑狼疮

SLE缓解评估:DORIS标准与医生判断的一致性及不一致原因

Remission in SLE-do DORIS criteria match the treating physician's judgment? A cross-sectional study to assess reasons for discordance.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该单中心横断面研究纳入233例SLE患者,评估DORIS缓解定义与主治医师独立缓解判断的一致性。99例(42.5%)符合任一DORIS缓解定义,126例被医师判断为缓解,53例(22.7%)存在不一致。医师缓解判断受疾病活动度、疾病和/或治疗相关损伤及ds-DNA抗体存在影响。

要点

  • DORIS缓解在门诊SLE患者中可实现,42.5%符合任一DORIS缓解定义。
  • DORIS缓解与医师判断不一致见于22.7%患者,医师判断缓解者更多。
  • 医师缓解判断与疾病活动度、损伤及ds-DNA抗体相关。

核心结论

  • DORIS缓解在SLE门诊患者中是可实现的目标,但DORIS缓解与主治医师独立缓解判断存在不一致,且医师判断为缓解的患者数量更多。

研究设计与样本

  • 单中心横断面研究,纳入2016年9月至2017年12月评估的233例SLE患者(87.6%女性),应用DORIS缓解定义并与临床诊疗后医师独立缓解判断进行比较,采用回归分析识别影响医师缓解判断的参数。

主要发现

  • 99例(42.5%)患者符合四种DORIS缓解定义中的任一种,126例患者根据医师判断处于缓解。
  • 53例(22.7%)患者在缓解评估中存在不一致。
  • 医师缓解判断受疾病活动度(OR 0.76,95% CI:0.63,0.90)、疾病和/或治疗相关损伤(OR 0.78,95% CI:0.62,0.98)及ds-DNA抗体存在(OR 2.47,95% CI:1.06,6.04)影响。

关键数值与推荐

  • DORIS缓解定义共四种,99例(42.5%)符合任一 definition。
  • 医师判断缓解者126例,与DORIS缓解不一致者53例(22.7%)。
  • 医师缓解判断的回归分析:疾病活动度OR 0.76(95% CI:0.63,0.90),损伤OR 0.78(95% CI:0.62,0.98),ds-DNA抗体OR 2.47(95% CI:1.06,6.04)。

临床怎么用

  • 临床采用DORIS缓解定义评估SLE患者时,需注意其与医师整体判断可能存在不一致,医师判断缓解者可能更多。
  • 疾病活动度、损伤及ds-DNA抗体状态可能影响医师对缓解的判断,评估时应综合考量这些因素。

局限性

  • 本研究为单中心横断面研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The definition of an accurate target for a treat-to-target approach in SLE has been challenging over past years, and recently the DORIS definitions of remission were presented by the international DORIS task force. It was our aim to assess the frequency of DORIS remission and LLDAS in our SLE cohort and their agreement with the treating physician's (DORIS-) independent remission judgement. Patient characteristics leading to lack of agreement and incoherence ought to be identified. METHODS: In this monocentric cross-sectional study, patients with SLE were enrolled and assessed between September 2016 and December 2017. DORIS remission definitions were applied and after the clinical consultation, the treating physicians gave his/her opinion on whether the patient was in remission. Regression analyses were performed to identify parameters influencing physician remission. RESULTS: A total of 233 patients were included (87.6% female); 99 (42.5%) patients fulfilled any of the four DORIS remission definitions, while 126 patients were in remission according to their physician's judgement. We observed discordance in the assessment of remission in 53 patients (22.7%). Physician remission was influenced by disease activity [odds ratio (OR) 0.76, 95% CI: 0.63, 0.90], disease and/or treatment-related damage (OR 0.78, 95% CI: 0.62, 0.98) and the presence of ds-DNA antibodies (OR 2.47, 95% CI: 1.06, 6.04). CONCLUSIONS: DORIS remission proved an achievable target in our outpatient clinic. Still we found discordance regarding DORIS remission and the treating physician's judgement with a greater number of patients considered in remission by their physicians.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Mucke J, Düsing C, Klose N, et al. Remission in SLE-do DORIS criteria match the treating physician's judgment? A cross-sectional study to assess reasons for discordance. Rheumatology (Oxford). 2021. PMID: 33493321. doi:10.1093/rheumatology/keab005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。